Overall, these results suggest that ETV1 and ERG, as well as MET activation, play an important role in prostate cancer cell migration and invasion, without affecting proliferation, and that MET receptor activation leads to an increase in these responses and MET repression to reversion. Here, ETV1 is linked to prostate carcinoma.